American Association of Tissue Banks, USA
Processing and classification of most human cell and cellular based tissue products has remained the same for decades. The basic homologous function of transplanted osteocondrial allografts and total joint replacements utilizing allografts has fundamentally followed suite. However, guidance from the United States Food and Drug Administration may shift some of these approaches and the grafts which are available for implantation or transplantation. The purpose of this presentation is to review and evaluate changes in processing, distribution, classifications and possible shift in the United States tissue banking community to medical devices and biologics as a result of this guidance providing and developing different options in arthroplasty.